Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
CVRx, Inc., a private medical device company, announced that the BeAT-HF phase III randomized clinical trial has completed enrollment in the...
CVRx, Inc., a private medical device company with a novel technology that treats patients suffering from chronic heart failure ("HF") and resistant...
CVRx, Inc., a private medical device company, announced today that its BeAT-HF phase III randomized clinical trial results were published in the...
CVRx, Inc., a private medical device company, announced new BeAT-HF trial results from late-breaking clinical science presented virtually at the...
CVRx, Inc., a private medical device company, announced today that it has received Premarket Approval (PMA) from the United States Food and Drug...
CVRx, Inc., a private medical device company, today announced the appointment of Tom Moore to the newly created, officer position of Vice President,...
CVRx, Inc., ein privater Hersteller medizinischer Geräte, erhielt eine Eigenkapitalfinanzierung von insgesamt $ 93 Millionen und eine neue...
CVRx, Inc., a private medical device company, has secured equity financing totaling $93 million and a new $20 million debt facility. CVRx plans to...
CVRx, ein weltweites Unternehmen für medizinische Geräte, gab heute bekannt, dass die ersten beiden Patienten in der klinischen Baroreflex Activation ...
CVRx, a global medical device company, today announced that the first two patients have been treated with the BAROSTIM NEO® System in the Baroreflex...
CVRx, Inc., a private medical device company, announced that it received Expedited Access Pathway (EAP) Designation by FDA for Barostim Therapy® for...
CVRx, Inc., a private medical device company, announced that positive results from the 'Barostim Therapy for Heart Failure' randomized, controlled...
CVRx, Inc., a private medical device company, announced that the results from the 'Barostim Therapy for Heart Failure' randomized, controlled...
CVRx, Inc., a private medical device company, announced that positive results from the Barostim Therapy for Heart Failure randomized, controlled...
CVRx, Inc., a private medical device company, announced that the results from the Barostim Therapy for Heart Failure randomized, controlled clinical...
CVRx, Inc., a privately held medical device company, announced today that it has received Humanitarian Device Exemption (HDE) approval from the U.S....
CVRx, Inc., a privately held medical device company, announced today that CE Marking has been granted to expand labeling of the Barostim neo System™...
CVRx, Inc., una compañía privada de dispositivos médicos, anunció hoy los primeros 10 pacientes con fallo cardiaco tratados con Barostim neo System™...
CVRx Inc., ein nicht börsennotiertes Medizintechnikunternehmen, verlautbarte heute die ersten zehn Herzinsuffizienz-Patienten an, die mit dem...
CVRx, Inc., société privée de dispositifs médicaux, a annoncé aujourd'hui que 10 premiers patients atteints d'insuffisance cardiaque avaient été...
CVRx, Inc., a private medical device company, announced today the first 10 heart failure patients treated with the Barostim neo System™ under CE Mark ...
CVRx, Inc., una compañía de dispositivos médicos privada, ha anunciado hoy que ha recibido la aprobación de marca CE de la National Standards...
CVRx, Inc., une société privée de dispositifs médicaux, a annoncé aujourd'hui avoir reçu la marque d'homologation CE par la National Standards...
CVRx, Inc., een bedrijf in privé-eigendom voor medische instrumenten kondigde vandaag aan dat zij van de National Standards Authority of Ireland...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.